ZLAB

Zai Lab Limited

Price

$26.23

return (12m)

-14.73%

p/e

-153.71

p/bv

47.66

DIVIDEND YIELD

0.00%

ZLAB price

Zai Lab

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ZLAB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.95%

3 months

59.16%

1 year

-14.73%

2 years

32.14%

5 years

-82.60%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ZLAB

Valuation

P/E

-153.71

Sector -3.73

Industry -3.73

P/BV

47.66

Sector 2.16

Industry 2.16

P/Revenue (PSR)

64.34

Sector 2.15

Industry 2.15

EV/EBITDA

-614.32

Sector -221.18

Industry -221.18

EV/EBIT

-563.31

Sector -47.52

Industry -47.52

P/EBITDA

-171.38

Sector -21.48

Industry -21.48

P/EBIT

-156.60

Sector -31.80

Industry -31.80

P/Total Assets

26.92

Sector 1.26

Industry 1.26

P/Net Current Assets

64.82

Sector -11.06

Industry -11.06

P/Working Capital

59.59

Sector -190.98

Industry -190.98

EPS

-0.17

Sector -1.77

Industry -1.77

BVPS

0.54

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

56.51%

Sector 41.11%

Industry 41.11%

EBITDA Margin

-43.35%

Sector -17,824.00%

Industry -17,824.00%

EBIT Margin

-47.28%

Sector -4,221,656.00%

Industry -4,221,656.00%

Operating Margin

-58.74%

Sector -34.64%

Industry -34.64%

Net Profit Margins

-41.86%

Sector -35.45%

Industry -35.45%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

-31.01%

Sector -56.40%

Industry -56.40%

ROA

-17.51%

Sector -59.80%

Industry -59.80%

ROIC

-76.51%

Sector -2,338.86%

Industry -2,338.86%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.13

Sector 2.89

Industry 2.89

Net Debt / EBITDA

13.40

Sector -14,697,933.03

Industry -14,697,933.03

Net Debt / EBIT

12.29

Sector -8.34

Industry -8.34

Net Debt / Equity

-1.02

Sector -34,400.71

Industry -34,400.71

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.56

Sector 0.46

Industry 0.46

Liabilities/Assets

0.44

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

25.52%

Sector -

Industry -

5Y Earnings CAGR

-23.20%

Sector -

Industry -

Fundamentals ZLAB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ZLAB Zai Lab Limited	$26.23	-14.73%	0.00%	-153.71	47.66	-31.01%	-41.86%
JNJ Johnson & Johnson	$275.23	58.90%	1.90%	31.48	7.79	24.76%	21.48%
PFE Pfizer Inc.	$28.64	23.67%	6.01%	37.36	1.91	5.11%	6.86%
ABBV AbbVie Inc.	$256.46	24.50%	2.66%	72.11	-76.75	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.74	-12.60%	3.97%	11.43	6.07	53.11%	35.32%
MRK Merck & Co. Inc.	$150.67	85.99%	2.24%	116.76	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$162.57	1.81%	1.98%	19.30	4.97	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$66.82	48.47%	3.75%	14.74	6.13	41.55%	18.85%
ZTS Zoetis Inc.	$75.81	-49.60%	2.76%	11.95	10.04	84.02%	27.77%
AMGN Amgen Inc.	$438.54	60.04%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$827.72	44.93%	0.44%	19.82	2.71	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.19	47.06%	0.00%	31.19	89.88	288.13%	24.86%
MCK McKesson Corporation	$917.36	33.47%	0.36%	20.52	-28.15	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$546.12	37.87%	0.00%	31.75	6.91	21.76%	35.00%
CAH Cardinal Health Inc.	$247.18	67.38%	0.83%	37.62	-21.79	-57.93%	0.62%
ARGX argenx SE	$1,038.19	43.79%	0.00%	3.11	3.48	112.18%	44.41%
HRMY Harmony Biosciences Holdings Inc.	$42.15	12.31%	0.00%	13.47	2.44	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ZLAB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Zai Lab

Zai Lab Limited

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2017

Time since IPO - 9 years

1.784

Employees

Zai Lab Limited (United States) is listed on the Nasdaq and has a market capitalization of $28.93 billion, with shareholders equity totaling $607.04 million.

The company employs approximately 1.784 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Zai Lab Limited reported $449.61 million in revenue, generating net income of $-188.21 million.

Key financial metrics include a P/E ratio of -153.71, a price-to-book (P/B) ratio of 47.66, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ZLAB.

Market cap

$28.93 billion

Net worth

$607.04 million

$607,037,000.00

Assets

$1.07 billion

$1,074,793,000.00

Total Shares Outstanding

1.12 billion

1,116,973,000

Average Daily Trading Volume

$987.76 Thousand

$987,764.00

Sector

Health Care

Industry

Biotechnology

ZLAB

ZLAB revenue and profits

Financial Results ZLAB

DRAG THE FRAME TO SEE MORE DATA

ZLAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$917.36 34,00% (12M)

P/E

20.52

0.36%

ROE

-137.16%

P/BV

-28.15

CAH - Cardinal Health

$247.18 67,38% (12M)

P/E

37.62

0.83%

ROE

-57.93%

P/BV

-21.79

JNJ - Johnson & Johnson

$275.23 58,90% (12M)

P/E

31.48

1.90%

ROE

24.76%

P/BV

7.79

ABBV - AbbVie

$256.46 24,50% (12M)

P/E

72.11

2.66%

ROE

-106.44%

P/BV

-76.75

MRK - Merck & Co.

$150.67 83,76% (12M)

P/E

116.76

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$162.57 0,71% (12M)

P/E

19.30

1.98%

ROE

25.77%

P/BV

4.97

PFE - Pfizer

$28.64 23,22% (12M)

P/E

37.36

6.01%

ROE

5.11%

P/BV

1.91

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$917.36 34,00% (12 M)

P/L

20.52

0.36%

ROE

-137.16%

P/VP

-28.15

CAH - Cardinal Health

$247.18 67,38% (12 M)

P/L

37.62

0.83%

ROE

-57.93%

P/VP

-21.79

JNJ - Johnson & Johnson

$275.23 58,90% (12 M)

P/L

31.48

1.90%

ROE

24.76%

P/VP

7.79

ABBV - AbbVie

$256.46 24,50% (12 M)

P/L

72.11

2.66%

ROE

-106.44%

P/VP

-76.75

MRK - Merck & Co.

$150.67 83,76% (12 M)

P/L

116.76

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$162.57 0,71% (12 M)

P/L

19.30

1.98%

ROE

25.77%

P/VP

4.97

PFE - Pfizer

$28.64 23,22% (12 M)

P/L

37.36

6.01%

ROE

5.11%

P/VP

1.91

Frequently Asked Questions

What is the price of Zai Lab (ZLAB) today?

A cotação de Zai Lab (ZLAB) hoje está em US$ 26.23, com uma variação de -14.73% em relação ao último ano. A cotação de Zai Lab (ZLAB) iniciou o ano negociando na casa dos US$ 17.64 e hoje está em US$ 26.23. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Zai Lab (ZLAB) e dados de ações do Ibovespa e mercados internacionais.

Quando Zai Lab (ZLAB) paga dividendos?

Zai Lab (ZLAB) não distribuiu dividendos no último ano.

Is Zai Lab (ZLAB) a good investment?

Atualmente, Zai Lab (ZLAB) está cotada a US$ 26.23, com um P/L de -153.71, representando um desvio de -10,322% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -14.73 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -14.73%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Zai Lab (ZLAB) stock?

Investir em ações de Zai Lab (ZLAB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Zai Lab (ZLAB) yield today?

A rentabilidade de Zai Lab (ZLAB) foi de 11.95% no último mês, -14.73% no último ano e -82.60% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Zai Lab (ZLAB) hoje, o investimento total seria de US$ 2,623.00, com base na cotação atual de US$ 26.23.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,236.63
Em 5 anos: US$ 456.40
Em 10 anos: US$ 2,623.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ZLAB

Zai Lab Limited

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ZLAB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ZLAB WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Zai Lab

Zai Lab Limited

United States

13 years

2017

1.784

PROFIT X PRICE ZLAB

Financial Results ZLAB

ZLAB cash flow

Asset, Revenue and Profit Growth - ZLAB

ZLAB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions